Top Headlines

Quality research key to Pharma viability say execs at Avoca Summit

Ensuring outsourced clinical research is of a high standard is critical to the viability of the pharma sector and requires cross industry collaboration according to leaders gathered at the Avoca Group’s Quality Summit.

News in brief

Contract sales deals expirations drive drop in revenues at PDI

Expiration of contract sales deals drove a 28 per cent drop in revenue at PDI and pushed financials below analysts’ expectations.

IGI hires after “notable shift” in pharma services demand

IGI Laboratories has boosted hiring after its pharmaceutical contract manufacturing unit experienced a “notable shift” in demand.

SNBL invests in animal welfare at US lab

SNBL USA has invested in ‘social housing’ at its lab in Everett, Washington citing ‘recent reductions’ in US non-human primate lab capacity as the driver.

Sales slump prompts BASi to plan more cost cutting steps

BASi is planning further cost cutting actions after continued weakness in toxicology led to a double-digit drop in revenue.

Global Industry News

Generic Lipitor drives jump in pharma revenues at Codexis from in-PharmaTechnologist.com

Codexis posted a jump in pharma sales after the Lipitor patent loss drove an uptick in demand for its atorvastatin intermediate.

USP and BPC harmonize first finished product monographs from in-PharmaTechnologist.com

Drug manufacturers will benefit from harmonisation of finished product monographs says the USP after a first of its kind collaboration with the BPC.

Dendreon to slash costs using production automation; CFO from in-PharmaTechnologist.com

Dendreon hopes to cut its cost of goods sold by two-thirds through automation of tasks at its cancer vaccine plants.

Round-up of new pharmaceutical manufacturing facilities from in-PharmaTechnologist.com

in-PharmaTechnologist.com presents the latest new facilities to spring up all over the world, including a plasma-based therapy expansion for Baxter, a North African foray for Julphar, and a supply chain step-up for Vetter.

On your radar